For the first time biotechnology has overtaken software as the US venture capitalists’ darling, according to the quarterly MoneyTree Report published by PricewaterhouseCoopers last week.

What is white biotech? Can it save the planet?

The Hungarian biotech sector is ahead of the rest of the new European Union member states pack, but it remains stymied by a lack of managers with a scientific background.

A new study shows that universities in the USA still rule the roost when it comes to biotech research, not to mention turning it into cash.

Who should profit from cutting-edge academic research: the scientists or the institution that funds them? Both, in a new biotech company launched by one of Sweden’s leading researchers.

In a landmark deal for Asia, the first takeover of European biotech firms by a counterpart in Singapore has been finalised.

Sweden is ranked number one among 31 European nations for its spending on R&D - but it is still looking for its first home-grown biotechnology product.

The competition to lure biotech investors and know-how is heating up in US states - and so are the legal battles between over fair and unfair incentives.

Philippe Pouletty is a man with a mission - to make France synonymous with biotechnology. He has his work cut out...